Digirad readies solid-state camera
Solid-state digital gamma camera developer Digirad next week will display a completed prototype of its Notebook Imager system for the first time at a Society of Nuclear Medicine meeting, according to Karen Klause, president and CEO of the San Diego
Solid-state digital gamma camera developer Digirad next week will display a completed prototype of its Notebook Imager system for the first time at a Society of Nuclear Medicine meeting, according to Karen Klause, president and CEO of the San Diego company. Digirad several months ago filed for 510(k) clearance of the system, which, if cleared, will be the first solid-state digital gamma camera on the market.
Digirad will show a wide range of clinical images collected with Notebook Imager, including bone, cardiac, liver, and thyroid scans. Notebook Imager is capable of the same range of applications as a standard gamma camera, with the exception of whole-body bone scans, which must be acquired a section at a time, due to the camera's small field-of-view. In addition, SPECT studies are conducted with patients seated in a rotating chair.
Digirad has been building a production capacity for the systems, and is also hiring a sales force to market the cameras directly in the U.S. The company is open to OEM relationships for distribution of Notebook Imager in international markets, Klause said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
